MedPath

Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression

Recruiting
Conditions
Colorectal Cancer
Registration Number
NCT03309722
Lead Sponsor
University of Southampton
Brief Summary

Molecular pathology of Colorectal Cancer: Investigating the role of novel molecular profiles, microRNA's and their targets in Colorectal Cancer progression

Detailed Description

Single centre observational cohort study Prospectively recruited patients biomarker evaluation and identification of novel biomarkers

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • colorectal cancer
Exclusion Criteria
  • hereditary CRC; tumours with extensive necrosis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
overall survival5 years
disease free survival5 years
local recurrence5 years
distant recurrence5 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Southampton

🇬🇧

Southampton, United Kingdom

University Hospital Southampton
🇬🇧Southampton, United Kingdom
Nadia Peppa, PhD
Contact
ahm@soton.ac.uk

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.